Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
82.85 EUR | +0.79% | -2.53% | +37.62% |
04-02 | Spain's Rovi Obtains US FDA Approval for Marketing Risvan as Schizophrenia Treatment | MT |
03-12 | Rovi, Partners to Form Entity for Advanced Therapies R&D | MT |
- Stock Market
- Equities
- ROVI Stock
- News Laboratorios Farmaceuticos Rovi, S.A.